Izana Bioscience Ltd.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Namilumab for Moderate-to-severe Axial Spondyloarthritis (NCT03622658) | Izana Bioscience Ltd. | 2018-09-06 |
Track Izana Bioscience Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.